Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Falk Nimmerjahn

Showing results (41-50 of 226) with videos related to

Pageof 23
Sort By:
Current Opinion in Immunology|February 13, 2007
Antibodies, Fc receptors and cancerFalk Nimmerjahn, Jeffrey V Ravetch
Advances in Immunology|November 6, 2007
Fc-receptors as regulators of immunityFalk Nimmerjahn, Jeffrey V Ravetch
Frontiers in Immunology|March 3, 2020
There Is (Scientific) Strength in Numbers: A Comprehensive Quantitation of Fc Gamma Receptor Numbers on Human and Murine Peripheral Blood LeukocytesChristina Kerntke, Falk Nimmerjahn, Markus Biburger
European Journal of Immunology|July 4, 2015
Three blocks are not enough--Blocking of the murine IgG receptor FcγRIV is crucial for proper characterization of cells by FACS analysisMarkus Biburger, Ines Trenkwald, Falk Nimmerjahn
Advances in Immunology|September 2, 2014
How immunoglobulin G antibodies kill target cells: revisiting an old paradigmMarkus Biburger, Anja Lux, Falk Nimmerjahn
Nature Reviews. Rheumatology|September 15, 2017
Differential antibody glycosylation in autoimmunity: sweet biomarker or modulator of disease activity?Michaela Seeling, Christin Brückner, Falk Nimmerjahn
Expert Review of Clinical Immunology|May 6, 2010
Mechanisms of action of intravenous immunoglobulinsAnne Baerenwaldt, Markus Biburger, Falk Nimmerjahn
Cell Reports|October 13, 2015
Pathways Responsible for Human Autoantibody and Therapeutic Intravenous IgG Activity in Humanized MiceInessa Schwab, Anja Lux, Falk Nimmerjahn
The Journal of Allergy and Clinical Immunology|July 30, 2020
Dissecting the mechanism of action of intravenous immunoglobulin in human autoimmune disease: Lessons from therapeutic modalities targeting Fcγ receptorsAnthony Shock, David Humphreys, Falk Nimmerjahn
Frontiers in Immunology|June 20, 2019
Immunomodulation in Primary Immune Thrombocytopenia: A Possible Role of the Fc Fragment of Romiplostim?Alexandra Schifferli, Falk Nimmerjahn, Thomas Kühne
Pageof 23

Showing results (41-50 of 226) with videos related to

Sort By:
Pageof 23
Current Opinion in Immunology|February 13, 2007
Antibodies, Fc receptors and cancerFalk Nimmerjahn, Jeffrey V Ravetch
Advances in Immunology|November 6, 2007
Fc-receptors as regulators of immunityFalk Nimmerjahn, Jeffrey V Ravetch
Frontiers in Immunology|March 3, 2020
There Is (Scientific) Strength in Numbers: A Comprehensive Quantitation of Fc Gamma Receptor Numbers on Human and Murine Peripheral Blood LeukocytesChristina Kerntke, Falk Nimmerjahn, Markus Biburger
European Journal of Immunology|July 4, 2015
Three blocks are not enough--Blocking of the murine IgG receptor FcγRIV is crucial for proper characterization of cells by FACS analysisMarkus Biburger, Ines Trenkwald, Falk Nimmerjahn
Advances in Immunology|September 2, 2014
How immunoglobulin G antibodies kill target cells: revisiting an old paradigmMarkus Biburger, Anja Lux, Falk Nimmerjahn
Nature Reviews. Rheumatology|September 15, 2017
Differential antibody glycosylation in autoimmunity: sweet biomarker or modulator of disease activity?Michaela Seeling, Christin Brückner, Falk Nimmerjahn
Expert Review of Clinical Immunology|May 6, 2010
Mechanisms of action of intravenous immunoglobulinsAnne Baerenwaldt, Markus Biburger, Falk Nimmerjahn
Cell Reports|October 13, 2015
Pathways Responsible for Human Autoantibody and Therapeutic Intravenous IgG Activity in Humanized MiceInessa Schwab, Anja Lux, Falk Nimmerjahn
The Journal of Allergy and Clinical Immunology|July 30, 2020
Dissecting the mechanism of action of intravenous immunoglobulin in human autoimmune disease: Lessons from therapeutic modalities targeting Fcγ receptorsAnthony Shock, David Humphreys, Falk Nimmerjahn
Frontiers in Immunology|June 20, 2019
Immunomodulation in Primary Immune Thrombocytopenia: A Possible Role of the Fc Fragment of Romiplostim?Alexandra Schifferli, Falk Nimmerjahn, Thomas Kühne
Pageof 23